Royce & Associates’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-62,000
Closed -$3.28M 1208
2018
Q4
$3.28M Hold
62,000
0.03% 601
2018
Q3
$3.93M Hold
62,000
0.03% 659
2018
Q2
$3.62M Sell
62,000
-16,000
-21% -$867K 0.03% 684
2018
Q1
$3.99M Hold
78,000
0.03% 634
2017
Q4
$4.64M Hold
78,000
0.03% 608
2017
Q3
$4.6M Hold
78,000
0.03% 599
2017
Q2
$4.35M Hold
78,000
0.03% 630
2017
Q1
$4.01M Hold
78,000
0.03% 654
2016
Q4
$3.49M Sell
78,000
-41,000
-34% -$1.82M 0.02% 676
2016
Q3
$5.66M Sell
119,000
-7,000
-6% -$362K 0.04% 554
2016
Q2
$7.01M Hold
126,000
0.05% 487
2016
Q1
$5.75M Buy
126,000
+33,000
+35% +$1.26M 0.04% 563
2015
Q4
$3.48M Buy
93,000
+37,000
+66% +$1.31M 0.02% 721
2015
Q3
$1.83M Buy
+56,000
New +$1.78M 0.01% 881

Other funds holding CONE

Royce & Associates's CONE Position: Q1 2019 in Review

Royce & Associates sold out of CyrusOne Inc Common Stock (CONE) in Q1 2019, closing a stake of 62,000 shares — an estimated $3.28M sold.

Royce & Associates first reported a position in CONE in Q3 2015 and held it in 14 quarters. The position peaked at $7.01M in Q2 2016. 377 funds tracked by Wall St. Rank hold CONE as of Q1 2019.

  • Royce & Associates reported no remaining CyrusOne Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Royce & Associates sold 62,000 CyrusOne Inc Common Stock shares in Q1 2019, an estimated $3.28M.
  • Royce & Associates first reported a position in CyrusOne Inc Common Stock in Q3 2015 and held it in 14 quarters.
  • Royce & Associates's CyrusOne Inc Common Stock position peaked at $7.01M in Q2 2016.
  • 377 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2019.

Based on Royce & Associates's 13F filing for Q1 2019, filed 9 May 2019.